These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16493356)

  • 21. Pharmacology of the anticholinesterase drugs; mestinon, prostigmin, tensilon and TEPP.
    RANDALL LO; CONROY CE; FERRUGGIA TM; KAPPELL BH; KNOEPPEL CR
    Am J Med; 1955 Nov; 19(5):673-8. PubMed ID: 13268462
    [No Abstract]   [Full Text] [Related]  

  • 22. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome.
    Oh SJ; Kim DS; Head TC; Claussen GC
    Muscle Nerve; 1997 Sep; 20(9):1146-52. PubMed ID: 9270671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.
    Sandroni P; Opfer-Gehrking TL; Singer W; Low PA
    Clin Auton Res; 2005 Feb; 15(1):51-3. PubMed ID: 15768203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of myasthenia. II.
    Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
    [No Abstract]   [Full Text] [Related]  

  • 27. Teaching NeuroImages: reversible ectropion in myasthenia gravis.
    Solé G; Perez F; Ferrer X
    Neurology; 2009 Oct; 73(16):e83. PubMed ID: 19841376
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and Safety of Subcutaneous Neostigmine for Ileus, Acute Colonic Pseudo-obstruction, or Refractory Constipation.
    Kram B; Greenland M; Grant M; Campbell ME; Wells C; Sommer C
    Ann Pharmacother; 2018 Jun; 52(6):505-512. PubMed ID: 29359574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
    GUINENA YH; NABI SA; TAHER Y
    J Egypt Med Assoc; 1956 Jun; 39(3):240-51. PubMed ID: 13367321
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyridostigmine in the treatment of orthostatic intolerance.
    Gales BJ; Gales MA
    Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diseases of the central nervous system. Myasthenia gravis.
    Havard CW
    Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
    [No Abstract]   [Full Text] [Related]  

  • 32. Tiopronin-induced myasthenia.
    Cherasse A; Maillefert JF; Henlin JL; Chassard D; Tavernier C
    Rev Rhum Engl Ed; 1999 Apr; 66(4):238-9. PubMed ID: 10339785
    [No Abstract]   [Full Text] [Related]  

  • 33. Minimally invasive gastric bypass in a morbidly obese patient with myasthenia gravis.
    Schumann R; Tarnoff M; Siddiqui ZI
    Obes Surg; 2004 Oct; 14(9):1273-6. PubMed ID: 15527647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myasthenia gravis].
    Havard CW; Lange MJ
    Recenti Prog Med; 1977 Jan; 62(1):9-26. PubMed ID: 323942
    [No Abstract]   [Full Text] [Related]  

  • 35. The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
    Foldes FF; Smith JC
    Ann N Y Acad Sci; 1966 Jan; 135(1):287-301. PubMed ID: 5221345
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety of enteral naloxone and i.v. neostigmine when used to relieve constipation.
    Thomas MC; Erstad BL
    Am J Health Syst Pharm; 2003 Jun; 60(12):1264-7. PubMed ID: 12845923
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute colonic pseudo-obstruction in paediatric oncology patients.
    Jessop M; Choo K; Little M
    J Paediatr Child Health; 2010 Nov; 46(11):698-9. PubMed ID: 21077980
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neostigmine treatment of acute pseudo-obstruction of colon (Ogilvie syndrome)].
    Koornstra JJ; Klaver NS; ter Maaten JC; Limburg AJ; van der Jagt EJ; van der Werf TS
    Ned Tijdschr Geneeskd; 2001 Mar; 145(12):586-9. PubMed ID: 11294000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyridostigmine bromide and constipation in Parkinson's disease.
    Sadjadpour K
    JAMA; 1983 Mar; 249(9):1148. PubMed ID: 6823069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.